Cargando…
Tumor Inflammation, Obesity, and Proliferative Status as Biomarkers in Gastroesophageal Adenocarcinoma
Recent epidemiological studies have shown that obesity, typically measured by increased body mass index (BMI), is associated with an increased risk of gastroesophageal adenocarcinoma (GEAC), but the contributing molecular and immune mechanisms remain unknown. Since obesity is known to promote chroni...
Autores principales: | Mukherjee, Sarbajit, Seager, R. J., Lee, Yong Hee, Conroy, Jeffrey M., Kalinski, Pawel, Pabla, Sarabjot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708257/ https://www.ncbi.nlm.nih.gov/pubmed/34945796 http://dx.doi.org/10.3390/jpm11121324 |
Ejemplares similares
-
Obesity-Specific Association of Statin Use and Reduced Risk of Recurrence of Early Stage NSCLC
por: Patnaik, Santosh K., et al.
Publicado: (2021) -
Pharmacogenomics based precision medicine in gastroesophageal cancers: way to move forward?
por: Shah, Shrunjal, et al.
Publicado: (2020) -
Visceral Obesity in Non-Small Cell Lung Cancer
por: Nitsche, Lindsay, et al.
Publicado: (2022) -
Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response
por: Pabla, Sarabjot, et al.
Publicado: (2021) -
Immune checkpoint inhibitors in resectable gastroesophageal cancers - a review
por: Mukherjee, Sarbajit, et al.
Publicado: (2022)